Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (opent nieuw venster)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Bron‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Geïndexeerd‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (opent nieuw venster)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (opent nieuw venster)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Bron‎: Cochrane Database Syst Rev 2018;4:CD011689.

Geïndexeerd‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (opent nieuw venster)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (opent nieuw venster)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Bron‎: Am J Obstet Gynecol.

Geïndexeerd‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (opent nieuw venster)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (opent nieuw venster)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Bron‎: S Afr Med J 2016;106(4):399-402.

Geïndexeerd‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (opent nieuw venster)

Prophylactic use of ergot alkaloids in the third stage of labour. (opent nieuw venster)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Bron‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Geïndexeerd‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (opent nieuw venster)

Treatment for primary postpartum haemorrhage. (opent nieuw venster)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Bron‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Geïndexeerd‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (opent nieuw venster)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (opent nieuw venster)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Bron‎: Obstet Gynecol 2001;98(3):386-90.

Geïndexeerd‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (opent nieuw venster)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (opent nieuw venster)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Bron‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Geïndexeerd‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (opent nieuw venster)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (opent nieuw venster)

Ragab A, Barakat R, Alsammani MA.

Bron‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Geïndexeerd‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (opent nieuw venster)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (opent nieuw venster)

Roach MK, Abramovici A, Tita AT.

Bron‎: Am J Perinatol 2013;30(7):523-8.

Geïndexeerd‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (opent nieuw venster)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (opent nieuw venster)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Bron‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Geïndexeerd‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (opent nieuw venster)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (opent nieuw venster)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Bron‎: Lancet Glob Health. 2023 11(2):e287-e295.

Geïndexeerd‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (opent nieuw venster)

Intravenous sulprostone infusion in the treatment of retained placenta. (opent nieuw venster)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Bron‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Geïndexeerd‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (opent nieuw venster)

Carbetocin for preventing postpartum haemorrhage. (opent nieuw venster)

Su LL, Chong YS, Samuel M.

Bron‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Geïndexeerd‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (opent nieuw venster)

Prostaglandins for preventing postpartum haemorrhage. (opent nieuw venster)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Bron‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Geïndexeerd‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (opent nieuw venster)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (opent nieuw venster)

Westhoff G, Cotter AM, Tolosa JE.

Bron‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Geïndexeerd‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (opent nieuw venster)